Empirical Wealth Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$586K Buy
18,674
+177
+1% +$7.47K 0.01% 618
2026
Q1
$1.02M Buy
18,497
+655
+4% +$31.2K 0.02% 351
2025
Q4
$667K Buy
17,842
+3,122
+21% +$127K 0.01% 424
2025
Q3
$596K Buy
14,720
+3,190
+28% +$105K 0.01% 431
2025
Q2
$294K Buy
11,530
+1,044
+10% +$22.8K 0.01% 542
2025
Q1
$224K Buy
+10,486
New +$234K 0.01% 584

Other funds holding PAHC

Empirical Wealth Management's PAHC Position: Q2 2026 in Review

Empirical Wealth Management increased its Phibro Animal Health (PAHC) stake by 0.96% in Q2 2026, buying an estimated $7.47K and bringing the position to 18,674 shares worth $586K. The position accounts for 0.01% of the portfolio, ranked #618.

Empirical Wealth Management first reported a position in PAHC in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.02M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Empirical Wealth Management held 18,674 shares of Phibro Animal Health worth $586K as of Q2 2026.
  • Empirical Wealth Management bought 177 Phibro Animal Health shares in Q2 2026, an estimated $7.47K.
  • Phibro Animal Health made up 0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #618 holding.
  • Empirical Wealth Management first reported a position in Phibro Animal Health in Q1 2025 and has held it in 6 quarters since.
  • Empirical Wealth Management's Phibro Animal Health position peaked at $1.02M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.